1
According to IMARC Group’s latest report, titled “
Parkinson’s Disease Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025”, the global parkinson’s disease treatment market grew at a CAGR of around 6% during 2014-2019. Looking forward, IMARC Group expects the global market to continue its moderate growth during 2020-2025.
Parkinson’s disease refers to a progressive nervous system disorder that affects movements in an individual. It is characterized by the degeneration of motor neurons in the brain that leads to the development of rigidity, tremors, motor impairment, depression and dementia. Healthcare professionals are widely utilizing medications, supportive therapies and surgical procedures to manage the symptoms of the disease in an efficient manner and offer comfort to the patient during a seizure. Some of the most commonly prescribed medications include dopamine agonists, anticholinergics and carbidopa-levodopa med